Plasma Levels of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Sudanese Patients with Vitiligo: A Case-Control Study.

Abstract

BACKGROUND Vitiligo is the most common pigmentary skin disorder. It is a multifactorial polygenic disease with epidermal melanocyte destruction. The cytokines profile found in vitiliginous patients was not fully elucidated. AIMS We sought to assess the autoimmune nature of vitiligo by comparing plasma levels of interleukin (IL)-17, IL-23, and transforming growth factor beta (TGF-β) in adult Sudanese vitiligo patients with matched control individuals. SUBJECTS AND METHODS Case-control study was conducted in Khartoum Dermatologic Teaching Hospital, in the period between July and December 2013. The cases were 42 adult Sudanese vitiligo patients matched with 43 control individuals. The cytokines were measured in the plasma by the quantitative "sandwich" ELISA. RESULTS Patients showed a significant lower median (25-75(th) inter-quartile) of TGF-β than control (0.042 [0.041-0.044] vs. 0.047 [0.042-0.049]; P ≤ 0.001). Both IL-17 and IL-23 showed no significant difference between cases and controls. IL-17 showed a significant inverse relationship when correlated with TGF-β (r = -0.24; P = 0.026) while showing direct relationship when correlated with age (r = 0.28; P = 0.009). CONCLUSION The positive findings detected in this study coincide with the important immunoregulatory role of the TGF-β, and support the autoimmune nature of the disease.

DOI: 10.4103/0019-5154.169136

Cite this paper

@article{Osman2015PlasmaLO, title={Plasma Levels of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Sudanese Patients with Vitiligo: A Case-Control Study.}, author={Ali Malik Osman and Maowia Mohamed Mukhtar and Khalid Hussein Bakheit and Hamdan Zaki Hamdan}, journal={Indian journal of dermatology}, year={2015}, volume={60 6}, pages={635} }